Reminder – Melanoma Consumer Breakfast this Saturday 6th October 2108

Sat 6th October 2018, 8:00-9:30am All members of the melanoma community are invited to attend a Melanoma Consumer Breakfast. The Breakfast is part of the Australasian Melanoma Conference – which also has great consumer forums. The program is on the website. All bookings can be made via the conference website

Melanoma survivors march to honour lost friends and raise awareness

Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly.

Free skin checks for South West community

The Bunbury Skin Cancer Clinic is partnering with melanomaWA to provide the community with free skin checks on February 24.

Townsville’s First Ever Twilight Melanoma March

She will next month join Townsville’s first ever twilight Melanoma March in honour of her mother, Gina Sellen, who lost her battle against the deadly cancer in 2016.

Cancer in the News

Feature Articles

Shutting Down Skin Cancer

Source: BU Today, March 2019 Melanoma is commonly caused by the damaging effects of ultraviolet light—from sources like sunlight and tanning beds—on the DNA of skin cells. This UV damage can activate genes that encourage precancerous cells to further mutate into full-blown skin cancer. At the same time, UV damage can turn off other genes […]


Posted in Melanoma News, Health Professionals, Of Interest

Artificial intelligence could predict spread of melanoma

Source: EurekAlert, March 2019 BEER-SHEVA, Israel…February 26, 2019 – An interdisciplinary team of researchers at Ben-Gurion University of the Negev (BGU) in Israel and the University of Texas Southwestern Medical Center (UTSW) in Dallas have developed groundbreaking technology to identify melanoma cells that are likely to metastasize to other parts of the body using artificial […]


Posted in Melanoma News, Health Professionals, Of Interest

FDA Approves Keytruda for Melanoma Patients After Tumor Resection

Source: Immuno-Oncology News, March 2019 The U.S. Food and Drug Administration has approved the use of Keytruda(pembrolizumab) as a treatment for melanoma patients with stage 3 disease — cancer cells have spread to the lymph nodes but not to distant organs — who have undergone complete resection of a tumor. The approval is based on data […]


Posted in Melanoma News, Regulatory, Publications

Diet May Impact Response to Immunotherapy in Patients With Melanoma

Source: OncLive, March 2019 Select patients with melanoma who consume a diet rich in fiber could see an improved response to treatment with immunotherapy, according to research presented during a webcast ahead of the 2019 AACR Annual Meeting. During the webcast preview of the event, Christine Spencer, PhD, a research scientist at the Parker Institute […]


Posted in Melanoma News, Health Professionals, Of Interest